Complement activation in human prion disease
The central event in the neuropathological process of prion diseases (PrD) is the accumulation of abnormal prion protein accompanied by severe neuronal loss. Despite the infectious nature of these diseases, no prominent immune response has been detected yet. However, recent studies have shown that c...
Main Authors: | Gabor G Kovacs, Philippe Gasque, Thomas Ströbel, Elisabeth Lindeck-Pozza, Michaela Strohschneider, James W Ironside, Herbert Budka, Marin Guentchev |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2004-02-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996103001748 |
Similar Items
-
The end of the BSE saga: do we still need surveillance for human prion diseases?
by: Herbert Budka, et al.
Published: (2015-11-01) -
Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients
by: Jean Y. Douet, et al.
Published: (2017-06-01) -
Molecular Pathology of Human Prion Diseases
Published: (2009-03-01) -
Prions: Current Progress in Advanced Research
by: Ryan A. Maddox
Published: (2014-01-01) -
New variant of Creutzfeldt-Jakob (vCJD) disease and other human prion diseases under epidemiological surveillance in Brazil
by: Vera Lúcia Gattás, et al.